At the same time, gene expression profiles analysis in USP8 mutant and wild-type tumors revealed that counter regulatory mechanisms may fine-tune the EGFR-MAPK pathway in tumor corticotroph cells [17]. This evidence concerns the gene USP8 and neoplasm.